Korro Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Korro Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Korro Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $146M, a 304% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $146M +$110M +304% Dec 31, 2023 10-K 2024-03-26
Q4 2022 $36.1M -$14.8M -29.1% Dec 31, 2022 10-K 2024-03-26
Q4 2021 $50.9M +$23.9M +88.7% Dec 31, 2021 10-K 2023-03-10
Q4 2020 $27M +$10.8M +66.6% Dec 31, 2020 10-K 2022-03-15
Q4 2019 $16.2M +$3.98M +32.5% Dec 31, 2019 10-K 2021-03-29
Q4 2018 $12.2M Dec 31, 2018 10-Q 2020-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.